Theranos’ end appears to be in sight. The company has laid off much of its remaining staff, according to The Wall Street Journal, reducing its workforce from 125 to about two dozen employees. That compares with 800 in late 2015. The latest cuts were aimed at saving cash in hopes of averting or delaying bankruptcy for a few more months, the story says. Of course, given everything that has happened to Theranos, including founder Elizabeth Holmes’ recent settlement of civil fraud charges with the SEC, some might be surprised Theranos still exists at all.